Australia markets open in 1 hour 59 minutes

SAVA Jan 2025 40.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
23.710.00 (0.00%)
As of 09:57AM EDT. Market open.
Full screen
Previous close23.71
Open23.71
Bid25.20
Ask26.05
Strike40.00
Expiry date2025-01-17
Day's range23.71 - 23.71
Contract rangeN/A
Volume1
Open interest18
  • GlobeNewswire

    Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease

    An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials.The DSMB Recommended the Phase 3 Trials of Simufilam Continue as Planned, Without Modification AUSTIN, Texas, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced a positive interim safety review of simufilam in on-going Phase 3 clinical trials in

  • GlobeNewswire

    Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease

    New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease.Results corroborate prior research from other academic researchers.These data once again confirm the biological activity of simufilam. AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the publication of new research that confirms the biological activity of simufilam. Simuf

  • GlobeNewswire

    Cassava Sciences Invited to Present in Four Upcoming Investor Conferences

    AUSTIN, Texas, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company committed to the treatment of Alzheimer’s disease dementia, today announced that it has been invited to present at the following investor conferences. Event:Morgan Stanley - 21stAnnual Global Healthcare ConferenceFormat:Fireside chat with Remi Barbier, President & CEODate:Monday, September 11, 2023Where:New York City Event:H.C. Wainwright - 25thAnnual Global Investment ConferenceForma